✦ LIBER ✦

A phase I pharmacokinetic study of PM00104 (Zalypsis®) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors

✍ Scribed by J. Capdevila, S. Clive, E. Casado, C. Michie…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of PM00104 (Zalypsis®) adm

✍ Massard, Christophe; Margetts, Jane; Amellal, Nadia; Drew, Yvette; Bahleda, Rati 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 171 KB

Erratum to: Phase I study of PM00104 (Za

✍ Massard, Christophe; Margetts, Jane; Amellal, Nadia; Drew, Yvette; Bahleda, Rati 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 49 KB

A phase I and pharmacokinetic study of D

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

A phase I and pharmacokinetic study of R

✍ Abigerges, D; Catimel, G; Klink Alakl, M; Bruno, R; Chabot, G; Ardiet, C; Nieman 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 143 KB

179 POSTER Phase I study of the novel an

✍ J.C. Soria; R. Plummer; A. Soto; C. Massard; H. Calvert; R. Prados; E. Angevin; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Phase I dose-escalating study of ES-285

✍ C. Massard, R. Salazar, J. P. Armand, M. Majem, E. Deutsch, M. García, A. Oaknin 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 591 KB